Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism
Completed · Early Phase 1 · Has a placebo group
Conditions studied: Osteoporosis, Age-Related
In brief
This study is designed to answer the question as to whether the sympathetic nervous system is an important determinant of bone metabolism in humans.
Key facts
- Study ID
- NCT02467400
- Run by
- Mayo Clinic
- People needed
- 165
- Starts
- 2015-07-01
- Expected to finish
- 2018-04-01
- Last updated by the study team
- 2019-02-06
Who can join
Age: 50 and older, up to 70. Sex: female. Healthy volunteers: accepted.
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.